0001209191-22-052568.txt : 20221004 0001209191-22-052568.hdr.sgml : 20221004 20221004200312 ACCESSION NUMBER: 0001209191-22-052568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221001 FILED AS OF DATE: 20221004 DATE AS OF CHANGE: 20221004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRASSO MARC CENTRAL INDEX KEY: 0001748894 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 221294019 MAIL ADDRESS: STREET 1: C/O KURA ONCOLOGY, INC. STREET 2: 3033 SCIENCE PARK ROAD, SUITE 220 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822933343 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 131 OYSTER POINT BLVD., SUITE 600 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-01 0 0001653087 Alector, Inc. ALEC 0001748894 GRASSO MARC C/O ALECTOR, INC. 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer Common Stock 2022-10-01 4 A 0 35702 0.00 A 35702 D Employee Stock Option (right to buy) 9.46 2022-10-01 4 A 0 23801 0.00 A 2032-10-01 Common Stock 23801 23801 D The reported shares are represented by restricted stock units, or RSUs, which vest in 12 equal quarterly installments beginning on March 1, 2023. Shares subject to the option vest in 48 equal monthly installments beginning on November 1, 2022. Exhibit 24 - Power of Attorney /s/ Marc Grasso 2022-10-04 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

The undersigned, as a Section 16 reporting person of Alector, Inc. (the
"Company"), hereby constitutes and appoints Jordon Hochstrasser, Danielle
Pasqualone and Grace Wong-Sarad, and each of them, as the undersigned's true
and lawful attorney-in-fact to:

1.     complete and execute Forms 3, 4 and 5 and other forms and all amendments
thereto as such attorney-in-fact shall in his discretion determine to be
required or advisable pursuant to Section 16 of the Securities Exchange Act of
1934 (as amended) and the rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and

2.     do all acts necessary in order to file such forms with the SEC, any
securities exchange or national association, the Company and such other person
or agency as the attorneys-in-fact shall deem appropriate.

The undersigned hereby ratifies and confirms all that said attorneys-in-fact and
agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys- in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with Section 16 of
the Securities Exchange Act of 1934 (as amended).

This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this first day of September, 2022.


Signature:  /s/ Marc Grasso
         ----------------------------------------

Print Name: Marc Grasso